Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies-Reference-Cited by-同舟云学术

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

Published:2009-02-20 Issue:4 Volume:23 Page:455-460
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Canducci Filippo,Sampaolo Michela,Marinozzi Maria Chiara,Boeri Enzo,Spagnuolo Vincenzo,Galli Andrea,Castagna Antonella,Lazzarin Adriano,Clementi Massimo,Gianotti Nicola

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference15 articles.

1. Raltegravir;Croxtall;Drugs,2008

2. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection;Cooper;N Engl J Med,2008

3. Raltegravir with optimized background therapy for resistant HIV-1 infection;Steigbigel;N Engl J Med,2008

4. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial;Grinsztejn;Lancet,2007

5. Potential for new antiretrovirals to address unmet needs in the management of HIV-1 infection;Moyle;AIDS Patient Care STDS,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea;Viruses;2022-11-18

2. Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance;AIDS;2020-09-14

3. Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients;International Journal of Antimicrobial Agents;2020-03

4. Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1;Antimicrobial Agents and Chemotherapy;2017-12

5. Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome;PLOS ONE;2017-02-17